SARS-CoV-2 Inhibitors Based on Disruption of the Ribosomal Frameshifting Element

  • Garcia-Blanco, Mariano (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/21 → 3/31/23

Funding

  • Arrakis Therapeutics: $211,036.00